Ofatumumab for TTP in a Patient with Anaphylaxis Associated with Rituximab

N Engl J Med. 2018 Jan 4;378(1):92-93. doi: 10.1056/nejmc1714146.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • ADAMTS13 Protein / deficiency
  • ADAMTS13 Protein / immunology
  • Anaphylaxis / chemically induced*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Female
  • Humans
  • Immunologic Factors / adverse effects*
  • Immunologic Factors / therapeutic use
  • Middle Aged
  • Purpura, Thrombotic Thrombocytopenic / drug therapy*
  • Rituximab / adverse effects*
  • Rituximab / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • Rituximab
  • ADAMTS13 Protein
  • ADAMTS13 protein, human
  • ofatumumab